Skip to main content
. 2023 Apr 11. Online ahead of print. doi: 10.1016/j.jtha.2023.02.033

Figure 6.

Figure 6

Platelet activation markers, coagulation factors, and NET-related measurements in long COVID. Comparisons between long haulers who visited a recovery clinic (nlh) and all other convalescents (nc) were analyzed for (A) FVIII (nc = 37, nlh = 29), p = .4275, (B) VWF (nc = 37, nlh = 29), p = .9770, (C) sP-selectin (nc = 37, nlh = 29), p = .0178, (D) PF4 (nc = 37, nlh = 29), p = .2325, (E) MPO (nc = 36, nlh = 29), p = .0447, (F) cfDNA (nc = 36, nlh = 29), p = .7957, (G) MPO-DNA complexes (nc = 34, nlh = 27), p = .0860, (H) H3Cit-DNA (nc = 33, nlh = 28), p = .0755, (I) NETosis induction levels (nc = 37, nlh = 29), p = .0088. Statistical analysis was performed using two-tailed Mann–Whitney tests. (J) NETosis induction levels of recovery clinic long haulers who experienced the most common symptoms and of all other convalescents (n = 17). Fatigue (n = 25), shortness of breath (n = 18), chest pressure/pain (n = 8), cough (n = 7), and lung damage (n = 7). A significant difference was found between the presented groups according to the Kruskal-Wallis test (p = .0306).